EUVIMEDEUVIMED entdecken
Open Access

Metabolic Bariatric Surgery in the Era of GLP-1 Receptor Agonists for Obesity Management

Kevin Lin, Ateev Mehrotra, Thomas C Tsai

JAMA Network Open · 25.10.2024 · 7 (10) · e2441380

DOI: 10.1001/jamanetworkopen.2024.41380 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 25.10.2024. Verfasst von Kevin Lin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts. Die Arbeit wurde bisher 83-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This cross-sectional study investigates rates of bariatric surgery and glucagon-like peptide-1 receptor agonist prescription among adults without diabetes in 2022 to 2023.

Autor:innen und Institutionen

  • Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.
  • Department of Health Services, Policy and Practice, Brown School of Public Health, Providence, Rhode Island.
  • Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.

Zitieren

APA

Lin, K., Mehrotra, A., & Tsai, T. C. (2024). Metabolic Bariatric Surgery in the Era of GLP-1 Receptor Agonists for Obesity Management. JAMA Network Open, 7(10), e2441380. https://doi.org/10.1001/jamanetworkopen.2024.41380

Vancouver

Lin K, Mehrotra A, Tsai TC. Metabolic Bariatric Surgery in the Era of GLP-1 Receptor Agonists for Obesity Management. JAMA Network Open. 2024;7(10):e2441380. doi:10.1001/jamanetworkopen.2024.41380

BibTeX
@article{Lin2024,
  author = {Lin, Kevin and Mehrotra, Ateev and Tsai, Thomas C},
  title = {Metabolic Bariatric Surgery in the Era of GLP-1 Receptor Agonists for Obesity Management},
  journal = {JAMA Network Open},
  year = {2024},
  volume = {7},
  number = {10},
  pages = {e2441380},
  doi = {10.1001/jamanetworkopen.2024.41380}
}
Kostenlos starten →